Difficult Intravenous Access in Pediatric Patients: Paramedical Care Using Ultrasound Guidance
Condition(s) studied
Investigational drug(s) / intervention(s)
peripheral intravenous catheterization performed with ultrasound guidance by a trained nurse: Intravenous catheterization using ultrasound-guidance to allow real-time visualization of target veins in pediatric patients with difficult intravenous access
Study summary
Obtaining intravenous access is difficult in the pediatric population. Ultrasound-guidance allows real-time visualization of target veins which are invisible and impalpable. We hypothesize that the use of ultrasound by a trained nurse team would improve the success rate of peripheral intravenous catheter insertion in pediatric patients with difficult intravenous access, compared to palpation of the vein alone.
For this study, when peripheral intravenous catheterization will be indicated in one of the participating pediatric services for an eligible patient, state-certified nurse investigators, trained in ultrasound guidance, will be contacted. After verification of eligibility criteria and all informed consents obtained, one of the investigators will randomize the patient in one of the 2 treatment groups under study: peripheral intravenous catheterization by visualization and palpation of the vein alone (standard of care) or by ultrasound guidance performed by a trained nurse.
Several outcomes will be measured and compared between the 2 groups (e.g. successful insertion of intravenous catheter, pain, adverse events).
Eligibility
Primary outcome measure(s)
- Number of Participants with success at first intravenous catheter insertion attempt — Day 0
Success at first attempt of intravenous catheter insertion with ultrasound-guidance compared to standard of care for pediatric patients with difficult venous access
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Chu Reims | Reims | France | Recruiting |
More CHU de Reims trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06465121 on ClinicalTrials.gov ↗ ← All trials in France